Bleeding prevalence in COVID-19 patients receiving intensive antithrombotic prophylaxis.

Détails

Demande d'une copieDemande d'une copie
ID Serval
serval:BIB_A56430066A5A
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Production externe
Titre
Bleeding prevalence in COVID-19 patients receiving intensive antithrombotic prophylaxis.
Périodique
Journal of thrombosis and thrombolysis
Auteur⸱e⸱s
Kessler C., Stricker H., Demundo D., Elzi L., Monotti R., Bianchi G., Llamas M., Spinedi L., Rossi D., Chiesa A.F., Pagnamenta A., Conti M., Casso G., Stoira E., Valenti E., Colucci G., Stussi G., Gerber B., Previsdomini M.
ISSN
1573-742X (Electronic)
ISSN-L
0929-5305
Statut éditorial
Publié
Date de publication
11/2020
Peer-reviewed
Oui
Volume
50
Numéro
4
Pages
833-836
Langue
anglais
Notes
Publication types: Letter ; Observational Study
Publication Status: ppublish
Mots-clé
Adult, Aged, Aged, 80 and over, Anticoagulants/administration & dosage, Anticoagulants/adverse effects, Betacoronavirus/pathogenicity, COVID-19, Coronavirus Infections/epidemiology, Coronavirus Infections/therapy, Coronavirus Infections/virology, Female, Fibrinolytic Agents/administration & dosage, Fibrinolytic Agents/adverse effects, Hemorrhage/chemically induced, Hemorrhage/epidemiology, Host-Pathogen Interactions, Humans, Male, Middle Aged, Pandemics, Pneumonia, Viral/epidemiology, Pneumonia, Viral/therapy, Pneumonia, Viral/virology, Prevalence, Risk Factors, SARS-CoV-2, Switzerland/epidemiology, Thrombosis/epidemiology, Thrombosis/prevention & control, Thrombosis/virology, Time Factors, Treatment Outcome, Young Adult
DOI
10.1007/s11239-020-02244-y
Pubmed
32803737
Web of science
000559691200001
Open Access
Oui
Création de la notice
19/12/2020 12:08
Dernière modification de la notice
20/12/2020 6:26
Données d'usage